Alder BioPharmaceutical

New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine
CP Wire
Wed, 04/25/18 - 11:06 am
Alder BioPharmaceutical
eptinezumab
migraines
New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine
Tue, 04/24/18 - 11:52 pm
Alder BioPharmaceutical
eptinezumab
migraine